Tokyo Morning Briefing Series: Therasense v. Becton Dickinson: The Decision, The Dissent, And The Future of Inequitable Conduct

Practices: Intellectual Property, Life Sciences

Becton Dickinson’s and Nova Biomedical’s counsel, Jim Badke and Sona De, will provide an insider’s look at the new inequitable conduct standard created by the long-awaited Therasense decision.  This enstallment of our monthly Tokyo Morning Briefing series will include an overview of the case, review the Federal Circuit’s split decision on the standard, and explore its strategic implications on inequitable conduct for prosecutors and litigators alike.
Cookie Settings